Fasting Insulin
Males, Age 20-29
The median fasting insulin for US males aged 20-29 in the US population is 7.1 uU/mL (43.0 pmol/L), with 90% of the population falling between 2.6 and 31.5 uU/mL.
NHANES 2017-March 2020 Pre-Pandemic 2017-2020 · Sample size: 453 participants · Unit: uU/mL
Percentile Distribution
Unit:
| Percentile | P5 | P25 | P50 | P75 | P95 |
|---|---|---|---|---|---|
| Value (uU/mL) | 2.6 | 4.3 | 7.1 | 13.7 | 31.5 |
2.6 4.3 7.1 13.7 31.5
P5 P25 P50 P75 P95
Data and Methodology
- Dataset
- NHANES 2017-March 2020 Pre-Pandemic ( NHANES 2017–2020 2020 , Survey-weighted percentiles from fasting subsample)
- Survey years
- 2017-2020
- Sample size
- 453 participants
- Reference population
- US civilian non-institutionalized males aged 20-29 from NHANES 2017-March 2020. Includes the full population (not restricted to healthy individuals) to reflect the population distribution.
- Exclusion criteria
-
- Missing fasting insulin measurement (LBXIN)
- Missing or zero fasting sample weight (WTSAF)
- Age outside 20-29 range
- Notes
- Percentiles computed using survey-weighted analysis (WTSAF weight, divided by 2 to pool two cycles). Fasting insulin measured as LBXIN in uU/mL from the fasting subsample.